Gyre Therapeutics Balance Sheet (2010-2026) | GYRE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	64.50M	44.35M	34.82M	75.39M	23.09M		8.10M	11.53M	2.23M	10.58M	8.68M	16.10M	15.90M	11.80M	3.69M	36.50M	40.40M	24.88M	37.50M	43.30M
Short-term Investments (Quarter)	5.37M	2.50M									7.57M	9.00M	9.23M	14.86M	14.80M	17.87M	19.60M	15.40M	12.30M	14.10M
Cash & Current Investments (Quarter)	69.87M	46.85M	34.82M	75.39M	23.09M		8.10M	11.53M	2.23M	10.58M	16.25M	25.10M	25.13M	26.66M	18.49M	54.37M	60.00M	40.28M	49.80M	57.40M
Receivables - Net (Quarter)	1.11M	1.82M	0.56M	5.00M	5.00M	17.14M	5.00M			15.16M	15.46M	18.62M	19.54M	19.80M	20.55M	24.86M	26.06M	31.23M	26.58M	28.08M
Receivables - Other (Quarter)								0.30M	1.20M	-1.10M	1.29M	1.30M	0.80M	4.96M	0.20M	0.20M	0.20M	0.20M	0.23M	0.26M
Receivables (Quarter)	1.11M	1.82M	0.56M	5.00M	5.00M	17.14M	5.00M			14.06M	16.75M	19.92M	20.34M	24.76M	20.75M	25.06M	26.26M	31.43M	26.81M	28.33M
Raw Materials (Quarter)						1.06M				0.92M	0.72M	1.17M	1.04M	0.79M	1.17M	1.21M	1.10M	0.97M	1.17M	0.77M
Work In Process (Quarter)						3.67M				2.00M	2.53M	2.92M	3.54M	2.93M	3.43M	4.21M	4.43M	6.31M	5.99M	7.71M
Finished Goods (Quarter)						1.40M				1.36M	1.68M	1.55M	1.80M	2.61M	3.28M	3.44M	3.32M	2.89M	4.18M	2.94M
Inventory (Quarter)						6.12M				4.28M	4.94M	5.63M	6.38M	6.34M	7.88M	8.86M	8.85M	10.17M	11.35M	11.43M
Prepaid Assets (Quarter)	8.32M	2.81M	1.32M	0.91M	2.16M	0.84M	0.92M	0.70M	1.17M	1.04M	1.79M	1.15M	1.51M	1.19M	8.16M	2.70M	2.87M	2.83M	3.76M	7.60M
Current Assets (Quarter)	73.96M	51.48M	36.70M	81.31M	30.25M	49.65M	14.01M	7.62M	5.13M	57.22M	62.72M	53.52M	54.81M	64.79M	68.45M	91.28M	98.58M	102.37M	91.73M	122.07M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.09M	0.97M	0.86M	0.16M	0.12M	17.71M	0.00M			23.29M	23.56M	23.67M	24.44M	23.88M	23.52M	23.40M	23.61M	23.60M	23.57M	27.28M
Long-Term Investments (Quarter)						40.63M				49.71M				64.31M				107.05M
Intangibles (Quarter)						2.04M				0.70M	0.20M	0.60M	0.18M	0.27M	5.58M	5.63M	4.85M	5.75M	5.84M	5.94M
Goodwill & Intangibles (Quarter)						2.04M				0.70M	0.20M	0.60M	0.18M	0.27M	5.58M	5.63M	4.85M	5.75M	5.84M	5.94M
Long-Term Deferred Tax (Quarter)						4.08M				4.70M	5.00M	5.08M	5.16M	5.62M	5.82M	6.13M	6.71M	6.87M	7.72M	9.28M
Other Non-Current Assets (Quarter)	0.87M	0.47M	0.47M	0.17M	0.17M	3.39M	0.17M	0.17M	0.17M	0.99M	0.80M	1.28M	2.77M	3.03M	5.56M	5.34M	5.32M	5.05M	4.94M	7.34M
Non-Current Assets (Quarter)	4.57M	4.19M	3.57M	2.06M	0.77M	35.10M	4.74M	4.77M	4.83M	59.32M	59.29M	67.41M	70.43M	60.62M	61.34M	61.36M	60.81M	63.76M	70.28M	77.18M
Assets (Quarter)	78.54M	55.66M	40.27M	83.37M	31.02M	84.75M	18.75M	12.39M	9.96M	116.54M	122.01M	120.93M	125.24M	125.41M	129.79M	152.65M	159.38M	166.13M	162.01M	199.25M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.86M	6.42M	4.71M	1.04M	0.04M	0.12M	0.02M	0.01M	0.16M	0.35M	0.33M	0.27M	0.30M	0.11M	0.12M	0.07M	0.56M	0.12M	0.27M	1.24M
Notes Payables (Quarter)
Dividends payables (Quarter)						7.56M
Payables (Quarter)	3.86M	6.42M	4.71M	1.04M	0.04M	7.68M	0.02M	0.01M	0.16M	0.35M	0.33M	0.27M	0.30M	0.11M	0.12M	0.07M	0.56M	0.12M	0.27M	1.24M
Accumulated Expenses (Quarter)	2.55M	1.47M	2.14M	0.91M	1.04M	9.26M	1.08M	0.72M	0.71M	11.94M	10.77M	10.51M	9.55M	10.62M	17.24M	14.92M	11.80M	14.36M	15.41M	18.81M
Other Accumulated Expenses (Quarter)	8.14M	4.07M	4.44M	0.95M	0.18M	0.12M	0.74M	2.07M	0.92M	1.37M	1.36M	1.48M	1.29M	0.23M	0.23M	0.22M	0.23M	0.23M	0.23M	5.08M
Short term Debt (Quarter)
Current Leases (Quarter)	1.84M	1.98M	1.91M	1.42M	0.38M	0.49M				0.21M	0.10M	0.66M	0.69M	0.71M	0.81M	0.62M	0.63M	0.64M	0.75M	1.39M
Current Taxes (Quarter)						2.10M				5.05M	6.47M	2.26M	2.84M	2.83M	0.57M	1.08M	2.65M	2.94M	3.13M	2.15M
Current Deferred Revenue (Quarter)	0.85M	0.23M				0.14M				0.04M	0.04M	0.06M	0.04M	0.06M	0.03M		0.06M	0.01M
Total Current Liabilities (Quarter)	17.25M	14.16M	13.19M	4.31M	1.64M	12.24M	6.84M	2.79M	1.78M	20.05M	19.49M	15.57M	14.72M	19.52M	18.99M	16.92M	15.91M	18.29M	19.79M	28.66M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)						0.12M				0.21M	0.20M	0.19M	0.18M	0.93M	0.91M	0.88M	0.87M	0.85M	0.84M	0.83M
Preferred Stock Liabilities (Quarter)						33.31M	33.31M	33.31M		64.53M				102.33M	104.90M	107.55M		113.03M	115.88M	22.43M
Minority Interest (Quarter)						29.70M				29.78M	32.13M	32.99M	35.30M	35.08M	36.18M	37.42M	35.49M	36.25M	35.68M	34.56M
Non-Current Deferred Tax Liability (Quarter)										2.50M				8.30M				9.60M
Operating Leases (Quarter)	0.55M	0.41M				0.12M				0.20M	0.17M	1.30M	1.10M	0.89M	0.78M	0.77M	0.54M	0.30M	0.07M	2.03M
Other Non-Current Liabilities (Quarter)							9.55M	4.61M	4.66M	0.05M	0.05M	0.05M	10.76M	5.67M	3.41M	3.20M	3.22M	1.45M	2.87M	2.74M
Total Non-Current Liabilities (Quarter)						12.54M	1.84M	2.79M	1.78M	38.02M	33.19M	27.54M	16.00M	21.34M	22.07M	20.00M	18.75M	22.40M	22.16M	31.59M
Total Liabilities (Quarter)	17.80M	14.57M	13.19M	4.31M	1.64M	12.54M	11.39M	7.40M	6.45M	38.06M	33.24M	27.58M	26.77M	27.00M	25.49M	23.20M	21.97M	23.85M	25.03M	34.34M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	60.74M	59.47M	27.08M	79.06M	29.38M	72.22M	77.33M	77.47M	85.32M	13.95M	88.77M	93.35M	98.47M	98.40M	104.30M	129.44M	137.41M	106.03M	136.99M	142.49M
Liabilities and Shareholders Equity (Quarter)	78.54M	55.66M	40.27M	83.37M	31.02M	84.75M	18.75M	12.39M	9.96M	116.54M	122.01M	120.93M	125.24M	125.41M	129.79M	152.65M	159.38M	166.13M	162.01M	199.25M
Retained Earnings (Quarter)	0.00M	443.75M	444.28M	444.63M	-370.50M	7.39M	-410.68M	-413.15M	-414.72M	-85.54M	-78.00M	-2.01M	-73.40M	-73.45M	138.18M	-70.30M	-66.70M	-0.78M	-77.67M	240.64M
Preferred Shares (Quarter)									33.31M
Treasury Shares (Quarter)						0.01M	0.01M	0.04M		0.01M				2.60M	2.60M	2.60M		2.60M	2.60M	3.70M

Research Tools

Datasets

Plans

Developers

Gyre Therapeutics Balance Sheet (2010-2026) | GYRE

Research Tools

Datasets

Plans

Developers

Gyre Therapeutics Balance Sheet (2010-2026) | GYRE

Create an account

Sign In

Reset Password